Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
52.90
-0.50 (-0.94%)
At close: Jan 22, 2026
12.55%
Market Cap5.68B
Revenue (ttm)9.52B
Net Income (ttm)537.75M
Shares Out107.42M
EPS (ttm)4.99
PE Ratio10.61
Forward PEn/a
Dividend1.40 (2.62%)
Ex-Dividend DateNov 20, 2025
Volume369,627
Average Volume292,088
Open53.10
Previous Close53.40
Day's Range52.70 - 53.50
52-Week Range44.10 - 65.80
Beta-0.20
RSI56.28
Earnings DateJan 28, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,798
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.

Financial Statements